| Literature DB >> 28076786 |
Gabriel Mizraji1, Maria Nassar2, Hadas Segev2, Hafiz Sharawi3, Luba Eli-Berchoer2, Tal Capucha2, Tsipora Nir2, Yaara Tabib2, Avraham Maimon2, Shira Dishon2, Lior Shapira3, Gabriel Nussbaum2, Asaf Wilensky4, Avi-Hai Hovav5.
Abstract
Whereas type I interferons (IFNs-I) were proposed to be elevated in human periodontitis, their role in the disease remains elusive. Using a bacterial-induced model of murine periodontitis, we revealed a prolonged elevation in IFN-I expression. This was due to the downregulation of TAM signaling, a major negative regulator of IFN-I. Further examination revealed that the expression of certain TAM components was reduced as a result of prolonged degradation of MYD88 by the infection. As a result of such prolonged IFN-I production, innate immunological functions of the gingiva were disrupted, and CD4+ T cells were constitutively primed by dendritic cells, leading to elevated RANKL expression and, subsequently, alveolar bone loss (ABL). Blocking IFN-I signaling restored proper immunological function and prevented ABL. Importantly, a loss of negative regulation on IFN-I expression by TAM signaling was also evident in periodontitis patients. These findings thus suggest a role for IFN-I in the pathogenesis of periodontitis.Entities:
Keywords: GAS6; Porphyromonas gingivalis, MYD88; interferon; mucosal immunity; oral mucosa; periodontitis
Mesh:
Substances:
Year: 2017 PMID: 28076786 DOI: 10.1016/j.celrep.2016.12.047
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423